HIV drug resistance transmission threshold survey in Bangkok, Thailand

Background Antiretroviral therapy (ART) began in Thailand in the Bangkok Metropolitan Area (BMA) in 1988 and scale-up began in 2001. The national first-line regimen is stavudine, lamivudine and nevirapine in fixed-dose combination, which is a regimen with a low genetic barrier for resistance. Because viral load and resistance testing are not widely available, unidentified HIV drug resistance (HIVDR) may occur during treatment and could be transmitted. Methods We undertook a threshold survey to assess HIVDR transmission in two subsets of recently infected individuals in the BMA. The first group consisted of returning blood donors tested at the Thai Red Cross National Blood Centre who seroconverted within the past 12 months. The second group comprised recently infected (as defined by BED assay) clients of the Thai Red Cross voluntary counselling and testing centre (VCT). Results Genotyping of 50 consecutive specimens each from blood donors and VCT clients during 2005–2006 showed no mutations associated with HIVDR in the reverse transcriptase or protease regions of the HIV pol gene. These results are categorized by the WHO HIV drug resistance threshold survey method as representing a low prevalence (<5%) of transmitted HIV drug resistance. Conclusions Every effort should be made to minimize the emergence of resistance in treated individuals and to prevent primary and secondary HIV transmission. To continue to monitor HIVDR transmission, Thailand has planned additional surveys – including longitudinal surveys – in these and additional groups of individuals.

• Publication year

  2008

• Venue

  Antiviral Therapy

• Publication date

  2008-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/135965350801302S14PMID 18575199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trends in HIV Prevalence , Estimated HIV Incidence , and Risk Behavior Among Men Who Have Sex With Men in Bangkok , Thailand , 2003 – 2007

  2009cited by this paper
• A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings

  2008cited by this paper
• HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance

  2007cited by this paper
• Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.

  2007cited by this paper
• Antisense applications for biological control

  2006cited by this paper
• Demographic predictors of a positive HIV test result among clients attending a large metropolitan voluntary counselling and testing centre in Thailand

  2006cited by this paper
• HIV prevalence among populations of men who have sex with men--Thailand, 2003 and 2005.

  2006cited by this paper
• The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis.

  2005cited by this paper
• Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells

  2005cited by this paper
• Scaling Up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach

  2005cited by this paper
• Avian flu: Isolation of drug-resistant H5N1 virus

  2005cited by this paper
• Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution

  2005cited by this paper
• 2-5A antisense treatment of respiratory syncytial virus.

  2005cited by this paper
• Intrapartum Exposure to Nevirapine and Subsequent Maternal Responses to Nevirapine-Based Antiretroviral Therapy

  2005cited by this paper
• Antisense approaches for inhibiting respiratory syncytial virus

  2005cited by this paper
• Avian influenza A (H5N1) infection in humans.

  2005cited by this paper
• Oseltamivir resistance during treatment of influenza A (H5N1) infection.

  2005cited by this paper
• Protection against lethal influenza virus challenge by RNA interference in vivo.

  2004cited by this paper
• Avian influenza A (H5N1) in 10 patients in Vietnam.

  2004cited by this paper
• Locked nucleic acid containing antisense oligonucleotides enhance inhibition of HIV‐1 genome dimerization and inhibit virus replication

  2004cited by this paper
• Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.

  2004cited by this paper
• Inhibition of influenza virus production in virus-infected mice by RNA interference.

  2004cited by this paper
• Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.

  2004cited by this paper
• Avian influenza--a challenge to global health care structures.

  2004cited by this paper
• Ecological and immunological determinants of influenza evolution

  2003cited by this paper
• Approaches for the sequence-specific knockdown of mRNA

  2003cited by this paper
• Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

  2003cited by this paper
• Antisense therapeutics: from theory to clinical practice.

  2003cited by this paper
• RNA as a Target for Developing Antivirals

  2003cited by this paper
• Pathogenesis of Avian Influenza A (H5N1) Viruses in Ferrets

  2002cited by this paper
• Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

  2002cited by this paper
• Antisense oligonucleotides: basic concepts and mechanisms.

  2002cited by this paper
• Antisense oligonucleotides delivered to the lysosome escape and actively inhibit the hepatitis B virus.

  2002cited by this paper
• A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001)

  2000cited by this paper
• Inhibitory effects of an antisense oligonucleotide in an experimentally infected mouse model of influenza A virus.

  2000cited by this paper
• A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients

  2000cited by this paper
• A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). HIV Netherlands Australia Thailand Research Collaboration.

  2000cited by this paper
• A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia.

  2000influential reference
• Biological Heterogeneity, Including Systemic Replication in Mice, of H5N1 Influenza A Virus Isolates from Humans in Hong Kong

  1999cited by this paper
• Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.

  1999cited by this paper
• In vitro and in vivo anti-influenza A virus activity of antisense oligonucleotides.

  1999cited by this paper
• Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.

  1999cited by this paper
• Inhibition of influenza virus replication by phosphorothioate and liposomally endocapsulated oligonucleotides.

  1998cited by this paper
• Fomivirsen approved for CMV retinitis.

  1998cited by this paper
• Antisense oligodeoxynucleotides against the BZLF1 transcript inhibit induction of productive Epstein-Barr virus replication.

  1996cited by this paper
• Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome

  1995cited by this paper
• The epidemiology of HIV infection and AIDS in Thailand.

  1991cited by this paper
• A report of three cases of AIDS in Thailand.

  1985cited by this paper
• Structure and function of the influenza virus genome.

  1983cited by this paper
• The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity.

  1980cited by this paper
• Biometry: The Principles and Practice of Statistics in Biological Research

  1969cited by this paper
• Resistant influenza A viruses in children treated with oseltamivir : descriptive study

  year unknowncited by this paper

• Procedural fairness in benefit package design: inclusion of pre-exposure prophylaxis of HIV in Universal Coverage Scheme in Thailand

  2023cites this paper
• The Impact of HIV Spending on Health Outcomes in Thailand

  2021cites this paper
• Brief Report: Prevalence Trend of Transmitted Drug Resistance in a Prospective Cohort of Thai People With Acute HIV Infection

  2021cites this paper
• Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting

  2020cites this paper
• RNA Secondary Structure as a First Step for Rational Design of the Oligonucleotides towards Inhibition of Influenza A Virus Replication

  2020cites this paper
• A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection

  2020cites this paper
• Secondary structure of the segment 5 genomic RNA of influenza A virus and its application for designing antisense oligonucleotides

  2019cites this paper
• Antiviral Activity of a New Class of Chemically Modified Antisense Oligonucleotides against Influenza А Virus

  2019cites this paper
• Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections

  2018cites this paper
• Transmission dynamics among participants initiating antiretroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand

  2018cites this paper
• Induced-Decay of Glycine Decarboxylase Transcripts as an Anticancer Therapeutic Strategy for Non-Small-Cell Lung Carcinoma

  2017cites this paper
• Delivery System Targeting Hemagglutinin of Influenza Virus A to Facilitate Antisense-Based Anti-H1N1 Therapy.

  2017cites this paper
• High antiviral effect of TiO2·PL–DNA nanocomposites targeted to conservative regions of (−)RNA and (+)RNA of influenza A virus in cell culture

  2016cites this paper
• Prevalence of Transmitted HIV-1 Drug Resistance among Young Adults Attending HIV Counselling and Testing Clinics in Kigali, Rwanda

  2016cites this paper
• Discovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral Resistance

  2016cites this paper
• Prevalence of Primary HIV Drug Resistance in Thailand Detected by Short Reverse Transcriptase Genotypic Resistance Assay

  2016cites this paper
• High Prevalence of Transmitted Drug Resistance in Acute HIV-Infected Thai Men Who Have Sex With Men

  2015cites this paper
• Nucleic acid-based drugs against emerging zoonotic viruses.

  2015cites this paper
• Small RNAs targeting the 5' end of the viral polymerase gene segments specifically interfere with influenza type A virus replication.

  2015cites this paper
• Transmitted Drug Resistance and Antiretroviral Treatment Outcomes in Non-Subtype B HIV-1–Infected Patients in South East Asia

  2014cites this paper
• Transmitted HIV drug resistance at the Thai Red Cross anonymous clinic in Bangkok: results from three consecutive years of annual surveillance.

  2014cites this paper
• Design, synthesis and anti-influenza virus activities of terminal modified antisense oligonucleotides

  2014cites this paper
• Pretreatment of Mice with Oligonucleotide prop5 Protects Them from Influenza Virus Infections

  2014cites this paper
• In vitro and in vivo protection against enterovirus 71 by an antisense phosphorothioate oligonucleotide

  2014cites this paper
• Basis of selection of first and second line highly active antiretroviral therapy for HIV/AIDS on genetic barrier to resistance: a literature review.

  2014cites this paper
• Surveillance of Transmitted HIV Drug Resistance in Antiretroviral-Naive Patients Aged less than 25 Years, in Bangkok, Thailand

  2014cites this paper
• HIV‐1 drug resistance‐associated mutations among antiretroviral‐naive thai patients with chronic HIV‐1 infection

  2013cites this paper
• Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients

  2013cites this paper
• Rapid and Simultaneous Detection of bla KPC and bla NDM by Use of Multiplex Real-Time PCR

  2013cites this paper
• Molecular Evolution of the HIV-1 Thai Epidemic between the Time of RV144 Immunogen Selection to the Execution of the Vaccine Efficacy Trial

  2013cites this paper
• Proteomic analysis at the subcellular level for host targets against influenza A virus (H1N1).

  2013cites this paper
• Systematic review of HIV drug resistance in Southeast Asia.

  2013cites this paper
• Assays for the identification of novel antivirals against bluetongue virus.

  2013cites this paper
• Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand

  2012cites this paper
• Short communication: Drug resistance mutations in the HIV type 1 protease and reverse transcriptase genes in antiretroviral-naive Vietnamese children.

  2012cites this paper
• The analysis of major impurities of lipophilic-conjugated phosphorothioate oligonucleotides by ion-pair reversed-phase HPLC combined with MALDI-TOF-MS

  2012cites this paper
• Minority HIV‐1 resistant variants in recent infection and in patients who failed first‐line antiretroviral therapy with no detectable resistance‐associated mutations in Thailand

  2012cites this paper
• Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world.

  2012cites this paper
• Setting up of HIV-1 Antiretroviral resistance testing methods and their clinical applications.

  2012cites this paper
• The Epidemiology of HIV-1 Transmitted Drug Resistance

  2012cites this paper
• Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings

  2011cites this paper
• Antisense oligonucleotide inhibits avian influenza virus H5N1 replication by single chain antibody delivery system.

  2011cites this paper
• Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.

  2011cites this paper
• Assessments of HIV drug resistance mutations in resource-limited settings.

  2011cites this paper
• HIV transmitted drug resistance in adult and pediatric populations in Panama.

  2011cites this paper
• The global status of HIV drug resistance: clinical and public-health approaches for detection, treatment and prevention.

  2011cites this paper
• Integrated surveillance of HIV care in low-income and middle-income countries

  2011cites this paper
• Drug resistance surveillance in resource-poor settings: current methods and considerations for TB, HIV, and malaria.

  2011cites this paper
• Antisense Oligonucleotide Induced Dystrophin Exon 45 Skipping at a Low Half-Maximal Effective Concentration in a Cell-Free Splicing System

  2011cites this paper
• Antisense oligonucleotides targeting the RNA binding region of the NP gene inhibit replication of highly pathogenic avian influenza virus H5N1.

  2011cites this paper
• HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study.

  2011cites this paper
• South-Eastern Asia

  2011cites this paper
• Resistance considerations in sequencing of antiretroviral therapy in low-middle income countries with currently available options

  2010cites this paper
• Hidden Drug Resistant HIV to Emerge in the Era of Universal Treatment Access in Southeast Asia

  2010cites this paper
• Animal Models for Influenza Virus Pathogenesis and Transmission

  2010cites this paper
• Varied Patterns of HIV-1 Drug Resistance on Failing First-Line Antiretroviral Therapy in South Africa

  2010cites this paper
• Families Suffering With HIV/AIDS: What Family Nursing Interventions Are Useful to Promote Healing?

  2010cites this paper
• Inhibition of highly pathogenic avian influenza virus H5N1 replication by the small interfering RNA targeting polymerase A gene.

  2009cites this paper
• Low Prevalence of Drug Resistance Transmitted Virus in HIV Type 1-Infected ARV-Naive Patients in Cambodia

  2009cites this paper
• Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

  2009cites this paper
• Oligonucléotide à 5’-triphosphate présentant une extrémité franche et ses utilisations

  2009cites this paper
• Advances and future directions in HIV surveillance in low- and middle-income countries

  2009cites this paper
• A combined solid phase extraction/capillary gel electrophoresis method for the determination of phosphorothioate oligodeoxynucleotides in biological fluids, tissues and feces.

  2009cites this paper
• Low Prevalence of HIV Type 1 Drug Resistance Mutations in Untreated, Recently Infected Patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: The ANRS 12134 Study

  2009cites this paper
• Oligonucleotides derived from the packaging signal at the 5′ end of the viral PB2 segment specifically inhibit influenza virus in vitro

  2009cites this paper
• Darunavir: pharmacokinetics and drug interactions.

  2008cites this paper
• Optimal use of maraviroc in clinical practice.

  2008cites this paper
• The World Health Organization's global strategy for prevention and assessment of HIV drug resistance

  2008cites this paper
• Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment

  2008cites this paper
• Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries

  2008cites this paper
• Short Communication Drug Resistance Mutations in the HIV Type 1 Protease and Reverse Transcriptase Genes in Antiretroviral-Naive Vietnamese Children

  year unknowncites this paper
• Hiv-1 Drug Resistance Mutations among Antiretroviral-naive Hiv-1– Infected Patients in Asia: Results from the Treat Asia Studies to Evaluate Resistance-monitoring Study on Behalf of the Treat Asia Studies to Evaluate Resistance-monitoring Study (taser-m)

  year unknowncites this paper